Equibles does not estimate personal net worth.
Get an email with a short summary when Airsculpt Technologies, Inc. publishes a filing, an earnings call transcript or a press release.
Get AIRS alertsDennis Dean is recorded as CEO at Airsculpt Technologies, Inc. (AIRS) since August 8, 2024. Airsculpt Technologies, Inc. reported in an 8-K filed August 9, 2024 that Dennis Dean was appointed Interim Chief Executive Officer, effective August 8, 2024. The proxy statement of Airsculpt Technologies, Inc. reports total compensation of $1,154,072 for Dennis Dean in fiscal 2024, including a base salary of $500,000. Disclosed compensation is on record for 4 fiscal years. Dennis Dean has spoken on 17 earnings calls across 1 company, most recently for Airsculpt Technologies, Inc. on November 7, 2025. Airsculpt Technologies, Inc. is classified in the Medical Care Facilities industry within the Healthcare sector. Other leadership on record at Airsculpt Technologies, Inc. includes Yogesh Jashnani (CEO and Board Member), Aaron Rollins (Chairman), Michael Doyle (Chairman and Board Member) and 7 others.
“On August 8, 2024, the Board appointed Dennis Dean, the Company's Chief Financial Officer, as the Interim Chief Executive Officer of the Company, effective as of August 8, 2024.”
“As I'd mentioned in my remarks last quarter, I'd like to thank the team at Aresculpt for the opportunity to lead this organization as Chief Financial Officer for the past four years.”
“I'd like to begin by expressing my gratitude to the team at AirSculpt for the opportunity to lead this organization as Chief Financial Officer over the past four years.”
“As mentioned, revenue for the quarter was $39.4 million, a 17.3% decline versus the prior year quarter with same-store revenue down approximately 24%. Cases declined 17.9% to 3,076 and average revenue per case for the quarter was $12,799, slightly higher than the first quarter of 2024.”
“As mentioned, revenue for the quarter was $39.2 million, a 17.7% decline versus the prior year quarter, with the same-store revenue down 22.6%. The decline in revenue this quarter was mainly driven by lower case and lead volume due to our reducing marketing spend and the challenging consumer spending environment.”
“Our third quarter results were in line with our expectations and included solid progress on our back-to-basics priorities.”
2024-08-08–present
Start not stated–2025-03-28
Last confirmed by a filing; no departure on record
Medical Care Facilities · Healthcare
CEO
2024-08-08–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Airsculpt Technologies, Inc. (AIRS) | Chief Financial Officer | $500,000 | $1,154,072 |
| 2023 | Airsculpt Technologies, Inc. (AIRS) | Chief Financial Officer | $500,000 | $1,326,401 |
| 2022 | Airsculpt Technologies, Inc. (AIRS) | Chief Financial Officer | $500,000 | $1,318,575 |
| 2021 | Airsculpt Technologies, Inc. (AIRS) | Chief Financial Officer | $247,917 | $16,270,135 |
